Global birth prevalence of spina bifida by folic acid fortification status: A systematic review and meta-analysis

American Journal of Public Health

Volumn 106, Issue 1, 2016, Pages e24-e34

  Atta, Callie A M ^a   Fiest, Kirsten M ^a,b   Frolkis, Alexandra D ^a   Jette, Nathalie ^a,b   Pringsheim, Tamara ^a   St Germaine Smith, Christine ^a   Rajapakse, Thilinie ^a   Kaplan, Gilaad G ^a   Metcalfe, Amy ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; VITAMIN B COMPLEX;

FEMALE; FORTIFIED FOOD; HEALTH; HUMAN; LEGISLATION AND JURISPRUDENCE; META ANALYSIS; PHYSIOLOGY; PREGNANCY; PREVALENCE; SPINAL DYSRAPHISM; STANDARDS; STATISTICS AND NUMERICAL DATA;

FEMALE; FOLIC ACID; FOOD, FORTIFIED; GLOBAL HEALTH; HUMANS; PREGNANCY; PREVALENCE; SPINAL DYSRAPHISM; VITAMIN B COMPLEX;

EID: 84951926014     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2015.302902     Document Type: Review

References (211)

1. Bol KA, Rickard RS, Kirby RS. Case fatality among infants with congenital malformations by lethality. Birth Defects Res A Clin Mol Teratol. 2004;70(9): 580-585.
2. Rosano A, Botto LD, Botting B, Mastroiacovo P. Infant mortality and congenital anomalies from 1950-1994: an international perspective. J Epidemiol Community Health. 2000;54(9):660-666.
3. Sachs BP, Fretts RC, Gardner R, Hellerstein S, Wampler NS, Wise PH. The impact of extreme prematurity and congenital anomalies on the interpretation of international comparisons of infant mortality. Obstet Gynecol. 1995;85(6):941-946.
4. Dolk H, Loane M, Garne E. The prevalence of congenital anomalies in Europe. In: Posada de la Paz M, Groft SC, eds. Rare Diseases Epidemiology: Advances in Experimental Medicine and Biology. New York, NY: Springer; 2010:349-364.
5. López-Camelo JS, Castilla EE, Orioli IM; Instituto Nacional de Genética Médica Populacional, Estudio Colaborativo Latino Americano de Malformaciones Congénitas. Folic acid flour fortification: impact on the frequencies of 52 congenital anomaly types in three South American Countries. Am J Med Genet A. 2010; 152A(10):2444-2458.
6. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impactoffolic acid fortificationoftheUS food supply on the occurrence of neural tube defects. JAMA. 2001;285(23):2981-2986.
7. DeWals P, Tairou F, Van Allen MI, et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med. 2007;357(2):135-142.
8. Czeizel AE, Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992;327(26): 1832-1835.
9. Herrmann W, Obeid R.The mandatory fortification of staple foods with folic acid: a current controversy in Germany. Dtsch Arztebl Int. 2011;108(15):249-254.
10. Sípek A, Horacek J, Gregor V, Rychtarikova J, Dzurova D, Masatova D.Neural tube defects inthe Czech Republic during 1961-1999: incidences, prenatal diagnosis and prevalences according to maternal age. J Obstet Gynaecol. 2002;22(5):501-507.
11. Forrester MB, Merz RD. First-year mortality rates for selected birth defects, Hawaii, 1986-1999. Am J Med Genet A. 2003;119A(3):311-318.
12. Yi Y, Lindemann M, Colligs A, Snowball C. Economic burden of neural tube defects and impact of prevention with folic acid: a literature review. Eur J Pediatr. 2011;170(11):1391-1400.
13. Liptak GS, Kennedy JA, Dosa NP. Youth with spina bifida and transitions: health and social participation in a nationally represented sample. J Pediatr. 2010;157(4): 584-588.e1.
14. Boyd PA, De Vigan C, Khoshnood B, et al. Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down's syndrome. BJOG. 2008;115(6):689-696.
15. Chan A, Robertson EF, Haan EA, Ranieri E, Keane RJ. The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects, South Australia 1986-1991. Br J Obstet Gynaecol. 1995;102(5):370-376.
16. Food Fortification Initiative. Enhancing Grains for Healthier Lives. Country profiles. Available at: http://www.ffinetwork.org/country-profiles/index.php.Accessed July 6, 2015.
17. Williams LJ, Rasmussen SA, Flores A, Kirby RS, Edmonds LD. Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics. 2005;116(3):580-586.
18. Wardlaw T, You D, Hug L, Amouzou A, Newby H. UNICEF report: enormous progress in child survival but greater focus on newborns urgently needed. Reprod Health. 2014;11:82.
19. UNICEF: Committing to Child Survival: A Promise Renewed Progress Report 2014. New York, NY: UNICEF; 2014.
20. Lawn JE, Kinney MV, Black RE, et al. Newborn survival: a multi-country analysis of a decade of change. Health Policy Plan. 2012;27(suppl 3):iii6-28.
21. Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012;379(9832):2151-2161.
22. Moher D, Liberati A, Tetzlaff J, Altman DG; The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 2009;6(7):e1000097.
23. Mason CA, Kirby RS, Sever LE, Langlois PH. Prevalence is the preferred measure of frequency of birth defects. Birth Defects Res A Clin Mol Teratol. 2005;73(10): 690-692.
24. Boyle MH. Guidelines for evaluating prevalence studies. Evid Based Ment Health. 1998;1(2): 37-39.
25. Loney PL, Chambers LW, Bennett KJ, Roberts JG, Strafford PW. Critical appraisal of health literature: prevalence or incidence of a health problem. Chronic Dis Can. 1998;19(4):170-176.
26. [No authors listed]. Birth defects surveillance data from selected states. Teratology. 1997;56(1-2):115-175.
27. Adama van Scheltema PN, Nagel HT, Brouwer OF, Vandenbussche FP. Outcome of children with prenatally diagnosed central nervous system malformations. Ultrasound Obstet Gynecol. 2003;21(1):41-47.
28. Afshar M, Golalipour MJ, Farhud D. Epidemiologic aspects of neural tube defects in South East Iran. Neuro-sciences (Riyadh). 2006;11(4):289-292.
29. Alasfoor D, Elsayed MK, Mohammed AJ. Spina bifida and birth outcome before and after fortification of flour with iron and folic acid in Oman. East Mediterr Health J. 2010;16(5):533-538.
30. Alembik Y, Dott B, Roth MP, Stoll C. Prevalence of neural tube defects in northeastern France, 1979-1994. Impact of prenatal diagnosis. Ann Genet. 1997;40(2):69-71.
31. Allen WP, Stevenson RE, Thompson SJ, Dean JH. The impact of prenatal diagnosis on NTD surveillance. Prenat Diagn. 1996;16(6):531-535.
32. Amini H, Antonsson P, Papadogiannakis N, et al. Comparison of ultrasound and autopsy findings in pregnancies terminated due to fetal anomalies. Acta Obstet Gynecol Scand. 2006;85(10):1208-1216.
33. Amini H, Axelsson O, Ollars B, Anneren G. The Swedish Birth Defects Registry: ascertainment and incidence of spina bifida and cleft lip/palate. Acta Obstet Gynecol Scand. 2009;88(6):654-659.
34. Archer NP, Langlois PH, Suarez L, Brender J, Shanmugam R. Association of paternal age with prevalence of selected birth defects. Birth Defects Res A Clin Mol Teratol. 2007;79(1):27-34.
35. Artama M, Ritvanen A, Gissler M, Isojarvi J, Auvinen A. Congenital structural anomalies in offspring of women with epilepsy-a population-based cohort study in Finland. Int J Epidemiol. 2006;35(2):280-287.
36. Asindi A, Al-Shehri A. Neural tube defects in the Asir Region of Saudi Arabia. Ann Saudi Med. 2001;21(1-2): 26-29.
37. Babcook CJ, Ball RH, Feldkamp ML. Prevalence of aneuploidy and additional anatomic abnormalities in fetuses with open spina bifida: population based study in Utah. J Ultrasound Med. 2000;19(9):619-623.
38. Baker D, Teklehaimanot S, Hassan R, Guze C. A look at a Hispanic and African American population in an urban prenatal diagnostic center: referral reasons, am-niocentesis acceptance, and abnormalities detected. Genet Med. 2004;6(4):211-218.
39. Bamforth SJ, Baird PA. Spina bifida and hydro-cephalus: a population study over a 35-year period. Am J Hum Genet. 1989;44(2):225-232.
40. Besser LM, Williams LJ, Cragan JD. Interpreting changes in the epidemiology of anencephaly and spina bifida following folic acid fortification of the U.S. grain supply in the setting of long-term trends, Atlanta, Georgia, 1968-2003. Birth Defects Res A Clin Mol Teratol. 2007;79(11):730-736.
41. Bird TM, Hobbs CA, Cleves MA, Tilford JM, Robbins JM. National rates of birth defects among hospitalized newborns. Birth Defects Res A Clin Mol Teratol. 2006;76(11):762-769.
42. Bol KA, Collins JS, Kirby RS. Survival of infants with neural tube defects in the presence of folic acid fortification. Pediatrics. 2006;117(3):803-813.
43. Botto LD, Lisi A, Bower C, et al. Trends of selected malformations in relation to folic acid recommendations and fortification: an international assessment. Birth Defects Res A Clin Mol Teratol. 2006;76(10):693-705.
44. Boulet SL, Correa-Villasenor A, Hsia J, Atrash H. Feasibility of using the national hospital discharge survey to estimate the prevalence of selected birth defects. Birth Defects Res A Clin Mol Teratol. 2006;76(11):757-761.
45. Boulet SL, Yang Q, Mai C, et al. Trends in the postfortification prevalence of spina bifida and anen-cephaly in the United States. Birth Defects Res A Clin Mol Teratol. 2008;82(7):527-532.
46. Bower C, D'Antoine H, Stanley FJ. Neural tube defects in Australia: trends in encephaloceles and other neural tube defects before and after promotion of folic acid supplementation and voluntary food fortification. Birth Defects Res A Clin Mol Teratol. 2009;85(4):269-273.
47. Bower C, de Klerk N, Hickling S, et al. Assessment of the potential effect of incremental increases in folic acid intake on neural tube defects in Australia and New Zealand. Aust N ZJ Public Health. 2006;30(4):369-374.
48. Bower C, Raymond M, Lumley J, Bury G. Trends in neural tube defects 1980-1989. Med J Aust. 1993;158(3): 152-154.
49. Boyd PA, Armstrong B, Dolk H, et al. Congenital anomaly surveillance in England-ascertainment deficiencies in the national system. BMJ. 2005;330(7481): 27.
50. Boyd PA, Wellesley DG, De Walle HE, et al. Evaluation of the prenatal diagnosis of neural tube defects by fetal ultrasonographic examination in different centres across Europe. J Med Screen. 2000;7(4):169-174.
51. Brazeau NK, Wentz SJ, Hansen AM, Holmes TM. An epidemiologic study of neural tube defects: Delta County, Michigan, 1969-1988. Fam Pract Res J. 1992;12(2): 205-212.
52. Bush RA, Smith TC, Honner WK, Gray GC. Active surveillance of birth defects among U.S. Department of Defense beneficiaries: a feasibility study. Mil Med. 2001; 166(2):179-183.
53. Candenas M, Villa R, Fernandez Collar R, et al. Maternal serum alpha-fetoprotein screening for neural tube defects. Report of a program with more than 30000 screened pregnancies. Acta Obstet Gynecol Scand. 1995;74 (4):266-269.
54. Canfield MA, Annegers JF, Brender JD, Cooper SP, Greenberg F. Hispanic origin and neural tube defects in Houston/Harris County, Texas. I. Descriptive epidemiology. Am J Epidemiol. 1996;143(1):1-11.
55. Canfield MA, Collins JS, Botto LD, et al. Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: findings from a multi-state population-based study. Birth Defects Res A Clin Mol Teratol. 2005;73(10): 679-689.
56. Canfield MA, Honein MA, Yuskiv N, et al. National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001. Birth Defects Res A Clin Mol Teratol. 2006;76(11):747-756.
57. Canfield MA, Marengo L, Ramadhani TA, Suarez L, Brender JD, Scheuerle A. The prevalence and predictors of anencephaly and spina bifida in Texas. Paediatr Perinat Epidemiol. 2009;23(1):41-50.
58. Carmichael SL, Shaw GM. Maternal life event stress and congenital anomalies. Epidemiology. 2000;11(1): 30-35.
59. Carmichael SL, Shaw GM, Kaidarova Z. Congenital malformations in offspring of Hispanic and African-American women in California, 1989-1997. Birth Defects Res A Clin Mol Teratol. 2004;70(6):382-388.
60. Carmichael SL, Shaw GM, Nelson V. Timing of prenatal care initiation and risk of congenital malformations. Teratology. 2002;66(6):326-330.
61. Castilla EE, Orioli IM, Lopez-Camelo JS, Dutra Mda G, Nazer-Herrera J. Preliminary data on changes in neural tube defect prevalence rates after folic acid fortification in South America. Am J Med Genet A. 2003; 123A(2): 123-128.
62. Centers for Disease Control and Prevention. Neural tube defect surveillance and folic acid intervention-Texas-Mexico border, 1993-1998. MMWRMorb Mortal Wkly Rep. 2000;49(1):1-4.
63. Centers for Disease Control and Prevention. Spina bifida and anencephaly before and after folic acid mandate-United States, 1995-1996 and 1999-2000. MMWR Morb Mortal Wkly Rep. 2004;53(17):362-365.
64. Centers for Disease Control and Prevention. Racial/ethnic differences in the birth prevalence of spina bifida-United States, 1995-2005. MMWR Morb Mortal Wkly Rep. 2009;57(53):1409-1413.
65. Chan A, Robertson EF, Haan EA, Keane RJ, Ranieri E, Carney A. Prevalence of neural tube defects in South Australia, 1966-91: effectiveness and impact of prenatal diagnosis. BMJ. 1993;307(6906):703-706.
66. Chaturvedi P, Banerjee KS. Spectrum of congenital malformations in the newborns from rural Maharashtra. Indian J Pediatr. 1989;56(4):501-507.
67. Chen BH, Carmichael SL, Selvin S, Abrams B, Shaw GM. NTD prevalences in central California before and after folic acid fortification. Birth Defects Res A Clin Mol Teratol. 2008;82(8):547-552.
68. Chen G, Pei LJ, Huang J, et al. Unusual patterns of neural tube defects in a high risk region of northern China. Biomed Environ Sci. 2009;22(4):340-344.
69. Cragan JD, Gilboa SM. Including prenatal diagnoses in birth defects monitoring: experience of the Metropolitan Atlanta Congenital Defects Program. Birth Defects Res A Clin Mol Teratol. 2009;85(1):20-29.
70. Cragan JD, Roberts HE, Edmonds LD, et al. Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis-United States, 1985-1994. MMWR CDC Surveill Summ. 1995;44(4): 1-13.
71. Cuckle H, Wald N. The impact of screening for open neural tube defects in England and Wales. Prenat Diagn. 1987;7(2):91-99.
72. De Wals P, Rusen ID, Lee NS, Morin P, Niyonsenga T. Trend in prevalence of neural tube defects in Quebec. Birth Defects Res A Clin Mol Teratol. 2003;67(11): 919-923.
73. Delshad S, Tabar AK, Samae H, et al. The incidence of selected congenital malformations during a two-year period in Tehran, Iran. Trop Doct. 2009;39(3): 156-158.
74. du Plessis L, Hunt RW, Fletcher AS, Riley MM, Halliday JL. What has happened with neural tube defects and womens' understanding of folate in Victoria since 1998? Med J Aust. 2008;189(10):570-574.
75. Ehara H, Ohno K, Ohtani K, Koeda T, Takeshita K. Epidemiology of spina bifida in Tottori Prefecture, Japan, 1976-1995. Pediatr Neurol. 1998;19(3): 199-203.
76. El-Awad MH, Sivasankaran S. Neural tube defects in Southwestern region of Saudi Arabia. Ann Saudi Med. 1992;12(5):449-452.
77. Ethen MK, Canfield MA. Impact ofincluding elective pregnancy terminations before 20 weeks gestation on birth defect rates. Teratology. 2002;66(suppl 1):S32-S35.
78. Eurenius K, Axelsson O, Cnattingius S, Eriksson L, Norsted T. Second trimester ultrasound screening performed by midwives; sensitivity for detection of fetal anomalies. Acta Obstet Gynecol Scand. 1999;78(2):98-104.
79. Farley TF, Hambidge SJ, Daley MF. Association of low maternal education with neural tube defects in Colorado, 1989-1998. Public Health. 2002;116(2): 89-94.
80. Feldkamp M, Friedrichs M, Carey JC. Decreasing prevalence of neural tube defects in Utah, 1985-2000. Teratology. 2002;66(suppl 1):S23-S28.
81. Feuchtbaum LB, Currier RJ, Riggle S, Roberson M, Lorey FW, Cunningham GC. Neural tube defect prevalence in California (1990-1994): eliciting patterns by type of defect and maternal race/ethnicity. Genet Test. 1999;3(3):265-272.
82. Finley WH, Gustavson KH, Hall TM, Hurst DC, Barganier CM, Wiedmeyer JA. Birth defects surveillance: Jefferson County, Alabama, and Uppsala County, Sweden. South Med J. 1994;87(4):440-445.
83. Forrester MB, Merz RD. Descriptive epidemiology of lipomyelomeningocele, Hawaii, 1986-2001. Birth Defects Res A Clin Mol Teratol. 2004;70(12):953-956.
84. Forrester MB, Merz RD. Rates of selected birth defects in relation tofolic acid fortification, Hawaii, 1986-2002. Hawaii Med J. 2005;64(12):300, 302-305.
85. Gardner BR, Strickland MJ, Correa A. Application of the automated spatial surveillance program to birth defects surveillance data. Birth Defects Res A Clin Mol Teratol. 2007;79(7):559-564.
86. Garne E, Loane M, Dolk H, et al. Prenatal diagnosis of severe structural congenital malformations in Europe. Ultrasound Obstet Gynecol. 2005;25(1):6-11.
87. Godwin KA, Sibbald B, Bedard T, Kuzeljevic B, Lowry RB, Arbour L. Changes in frequencies of select congenital anomalies since the onset of folic acid fortification in a Canadian birth defect registry. Can J Public Health. 2008;99(4):271-275.
88. Golalipour MJ, Ahmadpour-Kacho M, Vakili MA. Congenital malformations at a referral hospital in Gorgan, Islamic Republic of Iran. East Mediterr Health J. 2005;11 (4):707-715.
89. Northern Regional Survey Steering Group. Fetal abnormality: an audit of its recognition and management. Northern Regional Survey Steering Group. Arch Dis Child. 1992;67(7 spec no):770-774.
90. Gu X, Lin L, Zheng X, et al. High prevalence of NTDs in Shanxi Province: a combined epidemiological approach. Birth Defects Res A Clin Mol Teratol. 2007;79 (10):702-707.
91. Guillem P, Fabre B, Cans C, Robert-Gnansia E, Jouk PS. Trends in elective terminations of pregnancy between 1989 and 2000 in a French county (the Isere). Prenat Diagn. 2003;23(11):877-883.
92. Harmon JP, Hiett AK, Palmer CG, Golichowski AM. Prenatal ultrasound detection of isolated neural tube defects: is cytogenetic evaluation warranted? Obstet Gynecol. 1995;86(4 pt 1):595-599.
93. Hendricks KA, Simpson JS, Larsen RD. Neural tube defects along the Texas-Mexico border, 1993-1995. Am J Epidemiol. 1999;149(12):1119-1127.
94. Honein MA, Paulozzi LJ, Watkins ML. Maternal smoking and birth defects: validity of birth certificate data for effect estimation. Public Health Rep. 2001;116(4): 327-335.
95. Hwang BF, Magnus P, Jaakkola JJ. Risk of specific birth defects in relation to chlorination and the amount of natural organic matter in the water supply. Am J Epidemiol. 2002;156(4):374-382.
96. Jelliffe-Pawlowski LL, Shaw GM, Nelson V, Harris JA. Risk of mental retardation among children born with birth defects. Arch Pediatr Adolesc Med. 2003;157(6): 545-550.
97. Johnson KC, Rouleau J. Temporal trendsin Canadian birth defects birth prevalences, 1979-1993. Can J Public Health. 1997;88(3):169-176.
98. Johnson KM, Suarez L, Felkner MM, Hendricks K. Prevalence of craniorachischisis in a Texas-Mexico border population. Birth Defects Res A Clin Mol Teratol. 2004;70(2):92-94.
99. Julian-Reynier C, Philip N, Scheiner C, et al. Impact of prenatal diagnosis by ultrasound on the prevalence of congenital anomalies at birth in southern France. J Epidemiol Community Health. 1994;48(3):290-296.
100. Jung SC, Kim SS, Yoon KS, Lee JS. Prevalence of congenital malformations and genetic diseases in Korea. J Hum Genet. 1999;44(1):30-34.
101. Kadir RA, Sabin C, Whitlow B, Brockbank E, Economides D. Neural tube defects and periconceptional folic acid in England and Wales: retrospective study. BMJ. 1999;319(7202):92-93.
102. Källén B, Finnstrom O, Nygren KG, Olausson PO. In vitro fertilization (IVF) in Sweden: risk for congenital malformations after different IVF methods. Birth Defects Res A Clin Mol Teratol. 2005;73(3):162-169.
103. Kato K, Fujiki K. Incidence of congenital malformations in Tokyo Metropolitan Hospitals, 1979-1993. Brain Dev. 1996;18(3):230-233.
104. Khoury MJ, Botto L, Waters GD, Mastroiacovo P, Castilla E, Erickson JD. Monitoring for new multiple congenital anomalies in the search for human teratogens. Am J Med Genet. 1993;46(4):460-466.
105. Kirby R, Petrini J, Alter C. Collecting and interpreting birth defects surveillance data by Hispanic ethnicity: a comparative study. The Hispanic Ethnicity Birth Defects Workgroup. Teratology. 2000; 61(1-2):21-27.
106. Kulkarni ML, Mathew MA, Reddy V. The range of neural tube defects in southern India. Arch Dis Child. 1989;64(2):201-204.
107. Lazjuk G, Verger P, Gagniere B, Kravchuk Z, Zatsepin I, Robert-Gnansia E. The congenital anomalies registry in Belarus: a tool for assessing the public health impact of the Chernobyl accident. Reprod Toxicol. 2003; 17(6):659-666.
108. Lazjuk GI, Nikolaev DL, Novikova IV. Changes in registered congenital anomalies in the Republic of Belarus after the Chernobyl accident. Stem Cells. 1997;15(suppl 2):255-260.
109. Levi S, Schaaps JP, De Havay P, Coulon R, Defoort P. End-result of routine ultrasound screening for congenital anomalies: the Belgian Multicentric Study 1984-92. Ultrasound Obstet Gynecol. 1995;5(6):366-371.
110. Li SJ, Ford N, Meister K, Bodurtha J. Increased risk of birth defects among children from multiple births. Birth Defects Res A Clin Mol Teratol. 2003;67(10): 879-885.
111. Li Z, Ren A, Zhang L, et al. Extremely high prevalence of neural tube defects in a 4-county area in Shanxi Province, China. Birth Defects Res A Clin Mol Teratol. 2006;76(4):237-240.
112. Liu J, Yang GZ, Zhou JL, et al. Prevalence of neural tube defects in economically and socially deprived area of China. Childs Nerv Syst. 2007;23(10): 1119-1124.
113. Lovett AA, Gatrell AC. The geography of spina bifida in England and Wales. Trans Inst Br Geogr. 1988; 13(3):288-302.
114. Luben TJ, Messer LC, Mendola P, Carozza SE, Horel SA, Langlois PH. Urban-rural residence and the occurrence of neural tube defects in Texas, 1999-2003. Health Place. 2009;15(3):848-854.
115. Lys F, De Wals P, Borlee-Grimee I, Billiet A, Vincotte-Mols M, Levi S. Evaluation of routine ultrasound examination for the prenatal diagnosis of malformation. Eur J Obstet Gynecol Reprod Biol. 1989;30(2): 101-109.
116. Martínez de Villarreal LE, Arredondo P, Hernandez R, Villarreal JZ. Weekly administration of folic acid and epidemiology of neural tube defects. Matern Child Health J. 2006;10(5):397-401.
117. Milunsky A, Jick H, Jick SS, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA. 1989;262(20): 2847-2852.
118. Moore CA, Li S, Li Z, et al. Elevated rates of severe neural tube defects in a high-prevalence area in northern China. Am J Med Gen A. 12 1997;73(2): 113-118.
119. Morris JK, Wald NJ. Quantifying the decline in the birth prevalence of neural tube defects in England and Wales. J Med Screen. 1999;6(4):182-185.
120. Morris JK, Wald NJ. Prevalence of neural tube defect pregnancies in England and Wales from 1964 to 2004. J Med Screen. 2007;14(2):55-59.
121. Msamati BC, Igbigbi PS, Chisi JE. The incidence of cleft lip, cleft palate, hydrocephalus and spina bifida at Queen Elizabeth Central Hospital, Blantyre, Malawi. Cent Afr J Med. 2000;46(11):292-296.
122. Murshid WR. Spina bifida in Saudi Arabia: is consanguinity among the parents a risk factor? Pediatr Neurosurg. 2000;32(1):10-12.
123. Mytton J, Harrison V, McLoughlin A, Thompson R, Overton T. An evaluation of the recording of folic acid use in the South West Congenital Anomaly Register. Prenat Diagn. 2008;28(8):722-726.
124. National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention. Birth defects surveillance data from selected states, 1995-1999. Teratology. 2002;66(suppl 1): S129-S211.
125. [No authors listed]. Birth defect surveillance data from selected states, 1989-1996. Teratology. 2000;61(1-2): 86-160.
126. [No authors listed]. Birth defects surveillance data from selected states, 1996-2000. Birth Defects Res A Clin Mol Teratol. 2003;67(9):729-818.
127. [No authors listed]. Birth defects surveillance data from selected states, 1998-2002. Birth Defects Res A Clin Mol Teratol. 2005;73(10):758-853.
128. National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention. Birth defects surveillance data from selected states, 1999-2003. Birth Defects Res A Clin Mol Teratol. 2006;76(12):894-960.
129. [No authors listed]. Population-based birth defects surveillance data from selected states, 2001-2005. Birth Defects Res A Clin Mol Teratol. 2008;82(12):831-961.
130. Nembhard WN, Waller DK, Sever LE, Canfield MA. Patterns of first-year survival among infants with selected congenital anomalies in Texas, 1995-1997. Teratology. 2001;64(5):267-275.
131. Nikkilä A, Rydhstroem H, Kallen B, Jorgensen C. Ultrasound screening for fetal anomalies in southern Sweden: a population-based study. Acta Obstet Gynecol Scand. 2006;85(6):688-693.
132. Nikkilä A, Rydhstrom H, Kallen B. The incidence of spina bifida in Sweden 1973-2003: the effect of prenatal diagnosis. Eur J Public Health. 2006;16(6):660-662.
133. Njamnshi AK, Djientcheu VdeP, Lekoubou A, et al. Neural tube defects are rare among Black Americans but not in sub-Saharan Black Africans: the case of Yaounde-Cameroon. J Neurol Sci. 2008;270(1-2):13-17.
134. Ohtani K, Takeshita K. Consideration on the methodology of a simple and effective birth defect monitoring system. Congenit Anom (Kyoto). 2000;40(4): 269-274.
135. Olsson I, Dahl M, Mattsson S, Wendelius M, Astrom E, Westbom L. Medical problems in adolescents with myelomeningocele (MMC): an inventory of the Swedish MMC population born during 1986-1989. Acta Paediatr. 2007;96(3):446-449.
136. Omran M, McLoone P, Stone D, Aitken D, Crossley J. Factors limiting the effectiveness of prenatal screening for anencephaly and spina bifida in a high-risk area. Paediatr Perinat Epidemiol. 1993;7(4):461-468.
137. Pacheco SS, Braga C, Souza AI, Figueiroa JN. Effects of folic acid fortification on the prevalence of neural tube defects. Rev Saude Publica. 2009;43(4):565-571.
138. Persad VL, Van den Hof MC, Dube JM, Zimmer P. Incidence of open neural tube defects in Nova Scotia after folic acid fortification. CMAJ. 2002;167(3):241-245.
139. Petrova JG, Vaktskjold A. The incidence of neural tube defects in Norway and the Arkhangelskaja Oblast in Russia and the association with maternal age. Acta Obstet Gynecol Scand. 2009;88(6):667-672.
140. Pont SJ, Robbins JM, Bird TM, et al. Congenital malformations among liveborn infants with trisomies 18 and 13. Am J Med Genet A. 2006;140(16):1749-1756.
141. Purisch SE, DeFranco EA, Muglia LJ, Odibo AO, Stamilio DM. Preterm birth in pregnancies complicated by major congenital malformations: a population-based study. Am J Obstet Gynecol. 2008;199(3):287.e281-288.
142. Rajab A, Vaishnav A, Freeman NV, Patton MA. Neural tube defects and congenital hydrocephalus in the Sultanate of Oman. J Trop Pediatr. 1998;44(5): 300-303.
143. Rankin J, Glinianaia S, Brown R, Renwick M. The changing prevalence of neural tube defects: a population-based study in the north of England, 1984-96. Northern Congenital Abnormality Survey Steering Group. Paediatr Perinat Epidemiol. 2000;14(2): 104-110.
144. Rankin J, Pattenden S, Abramsky L, et al. Prevalence of congenital anomalies in five British regions, 1991-99. Arch Dis Child Fetal Neonatal Ed. 2005;90(5): F374-F379.
145. Rasmussen SA, Moore CA, Paulozzi LJ, Rho-denhiser EP. Risk for birth defects among premature infants: a population-based study. J Pediatr. 2001;138(5): 668-673.
146. Rebordosa C, Kogevinas M, Horvath-Puho E, et al Acetaminophen use during pregnancy: effects on risk for congenital abnormalities. Am J Obstet Gynecol. 2008;198 (2):178.e171-177.
147. Richmond S, Atkins J. A population-based study o the prenatal diagnosis of congenital malformation over 16 years. BJOG. 2005;112(10):1349-1357.
148. Riley MM, Halliday JL, Lumley JM. Congenital malformations in Victoria, Australia, 1983-95: an overview of infant characteristics. J Paediatr Child Health. 1998 34(3):233-240.
149. Robbins JM, Tilford JM, Bird TM, Cleves MA, Reading JA, Hobbs CA. Hospitalizations of newborns with folate-sensitive birth defects before and after fortification of foods with folic acid. Pediatrics. 2006;118(3): 906-915.
150. Robert E, Francannet C, Robert JM. Registries of malformations in the Rhone-Alps/Auvergne region. Value and limits of monitoring teratogenesis. 11 years' experience (1976-1986) [in French]. J Gynecol Obstet Bio Reprod (Paris). 1988;17(5):601-607.
151. Roberts HE, Moore CA, Cragan JD, Fernhoff PM Khoury MJ. Impact of prenatal diagnosis on the birth prevalence of neural tube defects, Atlanta, 1990-1991. Pediatrics. 1995;96(5 pt 1):880-883.
152. Rodríguez L, Sanchez R, Hernandez J, Carrillo L, Oliva J, Heredero L. Results of 12 years' combined maternal serum alpha-fetoprotein screening and ultrasound fetal monitoring for prenatal detection of fetal malformations in Havana City, Cuba. Prenat Diagn. 1997 17(4):301-304.
153. Rosano A, Smithells D, Cacciani L, et al. Time trends in neural tube defects prevalence in relation to preventive strategies: an international study. J Epidemiol Community Health. 1999;53(10):630-635.
154. Rull RP, Ritz B, Shaw GM. Neural tube defects and maternal residential proximity to agricultural pesticide applications. Am J Epidemiol. 2006;163(8): 743-753.
155. Sayed AR, Bourne D, Pattinson R, Nixon J, Henderson B. Decline in the prevalence of neural tube defects following folic acid fortification and its cost-benefit in South Africa. Birth Defects Res A Clin Mol Teratol. 2008;82(4):211-216.
156. Scott JE, Renwick M. Northern Region Fetal Abnormality Survey results 1987. J Pediatr Surg. 1990;25(4): 394-397.
157. Seto T, Nakagawa H, Morikawa Y, Nishijo M, Miura K, Kadoshima Y. Trend of congenital anomalies over 20 years ascertained by population-based monitoring in Ishikawa Prefecture, Japan. Congenit Anom (Kyoto). 2003; 43(4):286-293.
158. Sharma AK, Upreti M, Kamboj M, et al. Incidence o neural tube defectsofLucknow overa10year period from 1982-1991. Indian J Med Res. 1994;99:223-226.
159. Shaw GM, Carmichael SL, Kaidarova Z, Harris JA Differential risks to males and females for congenital malformations among 2.5 million California births, 1989-1997. Birth Defects Res A Clin Mol Teratol. 2003;67(12): 953-958.
160. Shaw GM, Carmichael SL, Nelson V. Congenital malformations in offspring of Vietnamese women in California, 1985-97. Teratology. 2002;65(3):121-124.
161. Shin M, Besser LM, Correa A. Prevalence of spina bifida among children and adolescents in metropolitan Atlanta. Birth Defects Res A Clin Mol Teratol. 2008; 82(11):748-754.
162. Shin M, Besser LM, Siffel C, et al. Prevalence of spina bifida among children and adolescents in 10 regions in the United States. Pediatrics. 2010;126(2):274-279.
163. Siffel C, Alverson CJ, Correa A. Analysis of seasonal variation of birth defects in Atlanta. Birth Defects Res A Clin Mol Teratol. 2005;73(10):655-662.
164. Simmons CJ, Mosley BS, Fulton-Bond CA, Hobbs CA. Birth defects in Arkansas: is folic acid fortification making a difference? Birth Defects Res A Clin Mol Teratol. 2004;70(9):559-564.
165. Sloka JS, Crowley M, Fernandez B, Maroun F. Bayesian small area cluster analysis of neural tube defects in Newfoundland. Can J Public Health. 2006;97(5):393-397.
166. Smithells RW, Sheppard S, Wild J. Prevalence of neural tube defects in the Yorkshire Region. Community Med. 1989;11(2):163-167.
167. Stevenson RE, Seaver LH, Collins JS, Dean JH. Neural tube defects and associated anomalies in South Carolina. Birth Defects Res A Clin Mol Teratol. 2004;70(9): 554-558.
168. Stoll C, Dott B, Alembik Y, Roth MP. Evaluation of routine prenatal diagnosis by a registry of congenital anomalies. Prenat Diagn. 1995;15(9):791-800.
169. Stoll C, Tenconi R, Clementi M. Detection of congenital anomalies by fetal ultrasonographic examination across Europe. Community Genet. 2001;4(4): 225-232.
170. Stone DH, Smalls MJ, Rosenberg K, Womersley J. Screening for congenital neural tube defects in a high-risk area: an epidemiological perspective. J Epidemiol Community Health. 1988;42(3):271-273.
171. Sumiyoshi Y, Hirahara F, Sakamoto S. Studies on the frequency of congenital malformations in Japan and Asian countries. Congenit Anom (Kyoto). 2000;40:S76-S86.
172. Summers AM, Farrell SA, Huang T, Meier C, Wyatt PR. Maternal serum screening in Ontario using the triple marker test. J Med Screen. 2003;10(3):107-111.
173. Tang Y, Ma CX, Cui W, et al. The risk of birth defects in multiple births: a population-based study. Matern Child Health J. 2006;10(1):75-81.
174. Tunçbilek E, Boduroglu K, Alikasifoglu M. Neural tube defects in Turkey: prevalence, distribution and risk factors. Turk J Pediatr. 1999;41(3):299-305.
175. Van Allen MI, Boyle E, Thiessen P, et al. The impact of prenatal diagnosis on neural tube defect (NTD) pregnancy versus birth incidence in British Columbia. J Appl Genet. 2006;47(2):151-158.
176. Velie EM, Shaw GM. Impact of prenatal diagnosis and elective termination on prevalence and risk estimates of neural tube defects in California, 1989-1991. Am J Epidemiol. 1996;144(5):473-479.
177. Viner-Brown SI, Cain R, Simon PR. Open neural tube defects among newborns in Rhode Island. Med Health R I. 2001;84(4):138-139.
178. Waitzman NJ, Romano PS, Scheffler RM. Estimates of the economic costs of birth defects. Inquiry. 1994;31 (2):188-205.
179. Waller DK, Pujazon MA, Canfield MA, Scheuerle AE, Byrne JL. Frequency of prenatal diagnosis of birth defects inHouston, Galveston and the Lower Rio Grande Valley, Texas 1995. Fetal Diagn Ther. 2000;15(6): 348-354.
180. Wen SW, Liu S, Joseph KS, Rouleau J, Allen A. Patterns of infant mortality caused by major congenital anomalies. Teratology. 2000;61(5):342-346.
181. Wertelecki W. Malformations in a Chornobyl-impacted region. Pediatrics. 2010;125(4): e836-e843.
182. Wu YW, Croen LA, Henning L, Najjar DV, Schembri M, Croughan MS. Potential association between infertility and spinal neural tube defects in offspring. Birth Defects Res A Clin Mol Teratol. 2006;76(10):718-722.
183. Xiao KZ, Zhang ZY, Su YM, et al. Central nervous system congenital malformations, especially neural tube defects in 29 provinces, metropolitan cities and autonomous regionsofChina: Chinese Birth Defects Monitoring Program. Int J Epidemiol. 1990;19(4):978-982.
184. Yang Q, Wen SW, Leader A, Chen XK, Lipson J, Walker M. Paternal age and birth defects: how strong is the association? Hum Reprod. 2007;22(3):696-701.
185. Ye R, Li S, Zheng J, et al. Prevalence of neural tube defects at birth in 30 counties and cities of China, 1993-2000. J Peking Univ. 2002;34(3):204-209.
186. Yuskiv N, Andelin CO, Polischuk S, et al. High rates of neural tube defects in Ukraine. Birth Defects Res A Clin Mol Teratol. 2004;70(6):400-402.
187. Zhu M, Druschel C, Lin S. Maternal birthplace and major congenital malformations among New York Hispanics. Birth Defects Res A Clin Mol Teratol. 2006;76(6):467-473.
188. Zlotogora J, Amitai Y, Leventhal A. Surveillance of neural tube defects in Israel: the effect of the recommendation for periconceptional folic acid. Isr Med Assoc J. 2006;8(9):601-604.
189. Zlotogora J, Haklai Z, Rotem N, et al. Relative prevalence of malformations at birth among different religious communities in Israel. Am J Med Genet A. 2003; 122A(1):59-62.
190. Zlotogora J, Haklai Z, Rotem N, Georgi M, Rubin L. The impact of prenatal diagnosis and termination of pregnancy on the relative incidence of malformations at birth among Jews and Muslim Arabs in Israel. Isr Med Assoc J. 2010;12(9):539-542.
191. Centers for Disease Control and Prevention. Spina bifida incidence at birth-United States, 1983-1990. MMWR Morb Mortal Wkly Rep. 1992;41(27):497-500.
192. Merlob P, Mogilner BM, Muhlbauer B, Aitkin I, Dulitzky F. Time trends (1978-86) of anencephaly and spina bifida in four hospitals affiliated with the International Clearinghouse: a warning. Isr J Med Sci. 1989; 25(8):441-444.
193. Richards IDG, Bentley HB, Glenny AM. A local congenital anomalies register: monitoring preventive interventions. J Public Health Med. 1999;21(1):37-40.
194. Cuckle HS, Wald NJ, Cuckle PM. Prenatal screening and diagnosis of neural tube defects in England and Wales in 1985. Prenat Diagn. 1989;9(6):393-400.
195. Gonçalves LF, Jeanty P, Piper JM. The accuracy of prenatal ultrasonography in detecting congenital anomalies. Am J Obstet Gynecol. 1994;171(6):1606-1612.
196. [No authors listed]. Birth defects surveillance data from selected states. Teratology. 1997;56(1-2): 115-175.
197. Skarsgard ED, Blair GK, Lee SK. Toward evidence-based best practices in neonatal surgical care-I: the Canadian NICU Network. J Pediatr Surg. 2003; 38(5):672-677.
198. Synnes AR, Berry M, Jones H, Pendray M, Stewart S, Lee SK. Infants with congenital anomalies admitted to neonatal intensive care units. Am J Perinat; 2004;21(4): 199-207.
199. Asindi AA, AlHifzi I, Bassuni WA. Major congenital malformations among Saudi infants admitted to Asir Central Hospital. Ann Saudi Med. 1997;17(2):250-253.
200. [No author listed]. Birth defects surveillance data from selected states, 1997-2001. Birth Defects Res A Clin Mol Teratol. 2004;70:677-771.
201. Lawrence M. Assessing the case for mandatory folate fortification: policy-making in the face of scientific uncertainties. Aust N ZJ Public Health. 2005;29(4):328-330.
202. Grosse SD, Waitzman NJ, Romano PS, Mulinare J. Reevaluating the benefits of folic acid fortification in the United States: economic analysis, regulation, and public health. Am J Public Health. 2005;95(11):1917-1922.
203. Borman B, Cryer C. Fallacies of international and national comparisons of disease occurrence in the epidemiology of neural tube defects. Teratology. 1990;42(4): 405-412.
204. Metcalfe A, Sibbald B, Lowry RB, Tough S, Bernier FP. Validation of congenital anomaly coding in Canada's administrative databases compared with a congenital anomaly registry. Birth Defects Res A Clin Mol Teratol. 2014;100(2):59-66.
205. Schoellhorn KJ, Collins S. Evaluation of passive surveillance for NTD-affected births in Alaska: a case verification study, birth years 1996-2007. J Registry Manag. 2010;37(1):4-9.
206. Hobbs CA, Hopkins SE, Simmons CJ. Sources of variability in birth defects prevalence rates. Teratology. 2001;64(suppl 1):S8-S13.
207. Mai CT, Kirby RS, Correa A, Rosenberg D, Petros M, Fagen MC. Public health practice of population-based birth defects surveillance programs in the United States. J Public Health Manag Pract. 2015;Epub ahead of print.
208. Khoury MJ, Flanders WD, James LM, Erickson JD. Human teratogens, prenatal mortality, and selection bias. Am J Epidemiol. 1989;130(2):361-370.
209. Bestwick JP, Huttly WJ, Morris JK, Wald NJ. Prevention of neural tube defects: a cross-sectional study of the uptake of folic acid supplementation in nearly half a million women. PLoS One. 2014;9(2):e89354.
210. Youngblood ME, Williamson R, Bell KN, Johnson Q, Kancherla V, Oakley GP II. 2012 update on global prevention of folic acid-preventable spina bifida and anencephaly. Birth Defects Res A Clin Mol Teratol. 2013;97 (10):658-663.
211. Crider KS, Bailey LB, Berry RJ. Folic acid food fortification-its history, effect, concerns, and future directions. Nutrients. 2011;3(3):370-384.